choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Ivabradine

Ivabradine Newsletter
  • Gold: Doctors battle against debilitating long-haul COVID 08 Sep 2021 09:34 GMT

    … of COVID-19 after vaccination. Preliminary research in Israel … doctors should target the symptoms patients are experiencing with treatments … fatigue can benefit from medicines used to treat … positive results from a drug called ivabradine. Other long-haulers …

  • New heart failure drug shows promise 29 May 2021 06:51 GMT

    … Foundation, a new drug namely Ivabradine has been approved for … “There are already several medicines available in the UK for … symptoms remain uncontrolled. Knowing doctors have another option to … pill. Nevertheless, the team is of the opinion that this treatment

  • Navigating Prior Authorization and Costs for HFrEF Drugs 11 May 2021 18:21 GMT

    … These newer medications include the I f inhibitor ivabradine (SHiFT … -HF and PIONEER-HF trials); the sodium-glucose transporter … vericiguat (VICTORIA trial). Although these new treatment options for HFrEF … process required for newer drugs for HFrEF, patients …

  • Existing heart failure drug may be effective in treating postural orthostatic tachycardia syndrome 16 Feb 2021 10:21 GMT

    … sympathetic nervous system activity. Trial participants experienced a reduction … the drug. Ivabradine is a novel agent that's FDA- … and Associate Professor of Medicine, UC San Diego School … Currently, there is no FDA-approved treatment for POTS and the …

  • Existing Heart Failure Drug May Treat Potential COVID-19 Long-Hauler Symptom 16 Feb 2021 04:41 GMT

    … nervous system activity. Trial participants experienced a reduction … the drug. “Ivabradine is a novel agent that’s FDA- … there is no FDA-approved treatment for POTS and the … Webster, Zoll Medical, Pfizer, Bristol Myers Squibb, and Janssen Pharmaceuticals.

  • Abbott gets DCGI nod for once-a-day heart failure, angina treatment drug 02 Sep 2020 12:10 GMT

    … received approval from the Drugs Controller General of India … a-day formulation, Ivabradine, used for treatment of chronic heart … formulation," Abbott Regional Medical Director Balagopal Nair said. … will help improve overall treatment adherence, leading to …

  • Do More HF Drugs Make It the Best or the Worst of Times? 03 Mar 2020 14:36 GMT

    … m Ileana Piña, professor of medicine at Wayne State University in … #47;valsartan came out, then ivabradine, and then everything started to … conducted all the trials that have proven these drugs. We' … is. They say the VICTORIA trial met its endpoint. What …

  • Trial of Amgen, Servier’s heart failure drug clears interim check 27 Feb 2020 11:47 GMT

    … -class chronic heart failure drug omecamtiv mecarbil, after their … review. The GALACTIC-HF trial’s data monitoring committee … s Corlanor (ivabradine) in 2015 provided some new treatment options however, … hit the mark in clinical trials, raising the prospect of …

  • Amgen, Servier heart failure drug clears trial hurdle 21 Mar 2019 11:35 GMT

    … class chronic heart failure drug omecamtiv mecarbil, after … Servier's Corlanor (ivabradine), which were both approved … current heart failure standard treatment in patients with chronic … recently started phase 1 trials of another Cytokinetics-developed …

  • Limited coverage drugs added to PharmaCare program 27 Nov 2018 15:27 GMT

    … more treatment options available to them as three limited coverage drugs were … . 30. Added are: ivabradine (Lancora) for the treatment of heart failure; obeticholic … grants full coverage for drugs, medical supplies or medical devices that otherwise would …

Satisfied with the content?

Continue to create your account.